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To form a gonad, germ cells (GCs) and somatic gonadal precursor cells (SGPs) must migrate to the
correct location in the developing embryo and establish the cell–cell interactions necessary to create
proper gonad architecture. During gonad morphogenesis, SGPs send out cellular extensions to ensheath
the individual GCs and promote their development. We have identiﬁed mutations in the raw gene that
result in a failure of the SGPs to ensheath the GCs, leading to defects in GC development. Using genetic
analysis and gene expression studies, we ﬁnd that Raw negatively regulates JNK signaling during gonad
morphogenesis, and increased JNK signaling is sufﬁcient to cause ensheathment defects. In particular,
Raw functions upstream of the Drosophila Jun-related transcription factor to regulate its subcellular
localization. Since JNK signaling regulates cell adhesion during the morphogenesis of many tissues, we
examined the relationship between raw and the genes encoding Drosophila E-cadherin and b-catenin,
which function together in cell adhesion. We ﬁnd that loss of DE-cadherin strongly enhances the raw
mutant gonad phenotype, while increasing DE-cadherin function rescues this phenotype. Further, loss
of raw results in mislocalization of b-catenin away from the cell surface. Therefore, cadherin-based cell
adhesion, likely at the level of b-catenin, is a primary mechanism by which Raw regulates germline-
soma interaction.
& 2012 Elsevier Inc. All rights reserved.Introduction
During organogenesis, different cell types must recognize one
another and control their relative positions and their shapes to
create an organ with the proper cell–cell interactions and archi-
tecture. The failure of cells to receive the proper cues from each
other and their surrounding microenvironment can affect cell
differentiation and proliferation, and may lead to cell death or
tumorigenesis. Defects in any of these steps may not only result in
the failure to form a cohesive and functional tissue, but are likely
to affect the viability and/or fertility of the organism.
One organ that is vital to the propagation of the species is the
gonad. In most animals, the gonad is formed early in embryogen-
esis from two cell types: the somatic gonadal precursor cells (SGPs)
and the germ cells (GCs) (reviewed in Richardson and Lehmann,
2010). SGPs and GCs are usually speciﬁed in different regions of the
developing embryo and must ﬁnd each other to create a functional
gonad. In mammals, GCs require the somatic Sertoli cells in males,
or the follicle cells in female, for the production of sperm and eggs
(Liu et al., 2010; Wainwright and Wilhelm, 2010). Similarly inll rights reserved.
gmail.com (J.J. Weyers),
u (M. Van Doren).Drosophila, defects in soma-germline interactions can result in a
failure to produce functional gametes (reviewed in Jemc, 2011).
Studies using the Drosophila gonad as a model have provided a
number of insights into the mechanisms that regulate the speci-
ﬁcation and migration of SGPs and GCs, while less is known about
the molecular mechanisms that regulate gonad morphogenesis
(reviewed in Jemc, 2011; Richardson and Lehmann, 2010).
In Drosophila, GCs are speciﬁed at the posterior pole of the
embryo, and migrate through the gut to reach the mesoderm,
where the SGPs are speciﬁed (reviewed in Jemc, 2011). Three
clusters of SGPs are speciﬁed on each side of the embryo within
parasegments (PS) 10, 11 and 12 of the mesoderm (Brookman
et al., 1992). An additional cluster of SGPs is speciﬁed in PS 13 of
males and females, but is only maintained in males (DeFalco et al.,
2003). As the GCs contact the SGP clusters, these cells come
together to form a cohesive tissue of intermingled GCs and SGPs
(Boyle and DiNardo, 1995). At this time, the SGPs also begin to
surround the GCs with cellular extensions in a process known as
GC ensheathment (Jenkins et al., 2003). By stage 15 of embry-
ogenesis, the gonad has compacted into its ﬁnal rounded struc-
ture and the GCs are almost completely surrounded by SGPs, such
that they make very little contact with one another (Boyle and
DiNardo, 1995; Jenkins et al., 2003). In males, as the GCs contact
the SGPs, they receive a signal from the SGPs that acts through the
JAK/STAT pathway to regulate male-speciﬁc GC proliferation and
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development, the GCs and SGPs will form either a testis or an
ovary and begin to produce gametes.
Previously, a number of genes have been identiﬁed that are
required for gonad morphogenesis, including those required for
proper GC–SGP interaction and GC ensheathment (Jenkins et al.,
2003; Li et al., 2003; Mathews et al., 2006; Van Doren et al., 2003;
Weyers et al., 2011). In particular, Drosophila E-cadherin (DE-cad),
which is encoded by the shotgun (shg) locus, is required at multiple
steps of gonad formation, including GC ensheathment (Jenkins et al.,
2003; Van Doren et al., 2003). shg mutants exhibit clumping of the
GCs, and a failure of SGPs to intermingle with, and send out
extensions around, the GCs (Jenkins et al., 2003). Interestingly,
overexpression of DE-cad speciﬁcally in the GCs results in a similar
phenotype, suggesting that the proper balance of adhesion protein
levels between the SGPs and GCs is critical for GC ensheathment
(Jenkins et al., 2003). Two other genes have also been demonstrated
to function in GC ensheathment, and may function through DE-cad.
The zinc ion transporter, Fear of intimacy (FOI), regulates DE-cad
post-transcriptionally to promote GC ensheathment (Mathews et al.,
2006; Van Doren et al., 2003). In addition, mutants for trafﬁc jam (tj),
which encodes a MAF family transcription factor, exhibit defects in
the ability of the SGPs to properly intermingle with the GCs (Li et al.,
2003). Analysis of tj mutant clones in adults revealed increased
levels of a number of cell adhesion proteins, including DE-cad, upon
tj mutation (Li et al., 2003), although it is unclear if tj regulates
embryonic gonad formation by affecting DE-cad. Together, these
results demonstrate that proper regulation of adhesion proteins is
critical for establishment of germline-soma interactions.
In a genetic screen for mutations that affect gonad morphogen-
esis, mutations in the gene raw were found to exhibit GC ensheath-
ment defects (Weyers et al., 2011). Similar to the mutants described
above, rawmutants exhibit GC clumping in the gonad, and the SGPs
fail to send out extensions to surround each GC. Previous studies of
raw have found that it is required for dorsal closure, CNS retraction,
and the morphogenesis of multiple tissues, including the salivary
gland and malpighian tubules (Jack and Myette, 1997). It appears to
negatively regulate JNK signaling during dorsal closure (Byars et al.,
1999), although the mechanism for this regulation is unclear. In this
paper, we examine the gonad phenotype exhibited by raw mutants,
and explore the molecular mechanisms by which it functions to
regulate germline-soma interactions.Materials and methods
Fly stocks
The following ﬂy stocks were used in this work: raw155.27 and
raw134.47 (Weyers et al., 2011), shg g317 (Tepass et al., 1996), tub-e-
cadWT (Pacquelet et al., 2003), tubulin-GAL4 (Lee and Luo, 1999),
P{Dfd-lacZ-HZ2.7} on X (Bergson and McGinnis, 1990), and pucE69
(obtained from Bohmann). The 68–77 enhancer trap (Simon et al.,
1990) expresses lacZ in the SGPs and was obtained from D. Godt and
manipulated as previously described (Weyers et al., 2011). bsk1,
jraIA109, UAS-bskDN, w1118, and Oregon R, were obtained from the
Bloomington Stock Center. The TRE-GFP reporter, which contains four
AP-1 binding sites downstream of an hsp70 promoter (Chatterjee and
Bohmann, 2012), was a gift from Bohmann. Mutations were main-
tained over lacZ or GFP marked balancer chromosomes to allow for
selection of mutants of the correct genotype.
Immunohistochemistry
Antibody stains were performed as previously described
(Jenkins et al., 2003; Moore et al., 1998), with the exception ofstage 17 embryos stained for STAT, which were sonicated to
increase antibody penetrance (Le Bras and Van Doren, 2006). The
following primary antibodies were used (dilutions; source):
mouse a-b-GAL (1:10,000; Promega), rabbit a-b-GAL (1:10,000;
Cappel), rabbit a-GFP (1:2,000; Torrey Pines Biolabs), mouse
a-GFP (1:50; Santa Cruz), rabbit a-pH3 (1:1000; Millipore),
mouse a-EYA (1:25; DSHB), mouse a-NRT BP106 (1:10; Develop-
mental Studies Hybridoma Bank (DSHB)), rat a-DE-cadherin
(DCAD2, 1:20; DSHB), mouse a-ARM (N27A1; 1:100; DSHB), chick
a-VASA (1:10,000; K. Howard), rat a-VASA (1:50; DSHB), guinea
pig a-TJ (1:1,000; generated using the same epitope as previously
described (Li et al., 2003)), rabbit a-JRA (1:1,500; Bohmann),
rabbit a-JUN (1:100; Santa Cruz), rabbit a-STAT (1:50; S. Hou).
Alexa 488, 546, and 633 conjugated secondary antibodies used at
1:500 from (Molecular Probes, Invitrogen). For diaminobenzidine
(DAB) detection, biotin conjugated secondaries (Jackson Immu-
noResearch) were used, and the stain was developed using the
ABC Elite kit (Vector Labs) using DAB as a substrate (Vector Labs).
Nuclei were stained by incubating embryos for 10 min in 1 mg/ml
40,6-diamidino-2-phenylindole (DAPI) in PBS with 0.1% Tween.
Embryos were staged using gut morphology according to Cam-
pos-Ortega and Hartenstein (Campos-Ortega and Hartenstein,
1985). Sex of embryos was determined when necessary using
P{Dfd-lacZ-HZ2.7} (Bergson and McGinnis, 1990) crossed in from
the paternal X chromosome. Fluorescently-stained embryos were
mounted in 70% glycerol containing 2.5% DABCO (Sigma) and
visualized using a Zeiss LSM 510 Meta or Confocor confocal
microscope. Non-ﬂuorescent immunostainings were mounted in
Aquatex (EMD Chemicals) and visualized using a Zeiss Axioskop
with Coolsnap camera and RS software (Photemetrics).
Quantitation of protein levels
JRA and TJ levels were compared in raw mutant (raw134.47/
raw155.27) and control (raw155.27/þ or raw134.47/þ) SGPs. The pixel
intensity of JRA was measured using the LSM 510 software across
the region of high TJ expression in each SGP (assumed to be the
nucleus) as well as 1–2 mm ﬂanking each side of the TJ staining.
The average intensity of JRA or TJ staining across 1 mm of the
ﬂanking region and nuclear region was calculated for each SGP.
The values for each cell were averaged together, and the standard
deviation was calculated.
As it is difﬁcult to quantitate ARM expression in comparable
regions across multiple samples, ARM levels were ranked sub-
jectively on a scale of 1–3 and the average expression was
calculated.
Western blot analysis
For Western blot analysis, embryos were collected from the
following cross: raw134.47/Cyo,twist-GAL4,UAS-GFP x raw155.27/
CyO, twist-GAL4, UAS-GFP, and sorted into GFP positive and GFP
negative populations using a COPAS Select embryo sorter (Union
Biometrica). For analysis of JRA and DE-cad levels, embryos were
lysed in RIPA buffer containing protease inhibitors (Roche),
sodium orthovanadate and Ser/Thr phosphatase inhibitors
(Sigma). Samples were run on 10% SDS-PAGE and protein expres-
sion was compared in control embryos (GFP positive population)
and raw mutant embryos (GFP negative population). For analysis
of phospho-ARM levels, embryos were lysed in NP-40 lysis buffer
containing protease inhibitors (Roche) and Ser/Thr phosphatase
inhibitors (Sigma). Samples were run on 8% SDS-PAGE and protein
expression was compared in control embryos (Oregon R) and raw
mutant embryos (GFP negative population). Immunoblotting was
performed with the following antibodies according to standard
methods: rabbit a-JUN was used at (1:1000; Santa Cruz), mouse
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DSHB), mouse a-ARM (N27A1; 1:1000; DSHB), and phospho-b-
catenin (1:1000; Cell Signaling). HRP conjugated secondaries
(Jackson Immunoresearch) were used at 1:1000–2000 and
detected used the Amersharm ECL or ECL-plus kit (GE Health-
care). Relative levels of Jun and DE-cad were determined using
ImageJ software.
Generation of rescue construct
UAS-rawRA was generated by inserting the rawRA transcript
into pUASpB (a modiﬁed version of pUASP (Rorth, 1998) with an
attB site for phiC31 mediated integration). The 50 fragment
of rawRA was ampliﬁed by PCR from RE05256 (Berkeley
Drosophila Genome Project) using the following primers: 50-
CATGAGCGGCCGCGCCGCCACCATGAAAACTGAAAGCAGCAGTTATC-30
and 50-CGGGCACCACATTGCATCTGGCCTTTGCTCGCCATGCATTCA-
GAACTTCT-30. The 30 fragment was derived from GH23250
(Berkeley Drosophila Genome Project) that was used to generate
a pUASpB-rawRB transgene. This fragment was isolated by diges-
tion using XcmI and XbaI. Both fragments were ligated into
pUASpB that was digested with NotI and XbaI, and the construct
was conﬁrmed by sequencing. This construct was inserted into
ﬂies using phiC31 integration into P{CARYP}attP40 (Groth et al.,
2004; Markstein et al., 2008) by Genetics Services (Cambridge,
Massachusetts).Results
Raw is required for GC ensheathment by SGPs
Previously, we identiﬁed two mutant alleles of a gene that
exhibited defects in the ability of the SGPs to ensheath the GCs
and mapped this gene to the raw locus (Weyers et al., 2011). In
order to further examine the raw mutant phenotype, we scored
the frequency of ensheathment defects in raw mutants using a
lacZ enhancer trap, called 68–77, which expresses lacZ cytoplas-
mically in the SGPs (Boyle and DiNardo, 1995; Simon et al., 1990;
Warrior, 1994). While only 5% of gonads exhibited defects in GCFig. 1. raw mutants exhibit ensheathment defects. (A) and (B) Stage 15 gonads staine
raw155.27, 68–77. Embryos are immunostained for VASA (blue, germ cells), 68–77-lacZ
(C) and (D) Stage 12 gonads stained to examine EYA expression as an indicator of SGP s
68–77. (D) raw134.47, 68–77/raw155.27, 68–77 gonad. (E) and (F) Expression of TJ in sta
germ cells). (E) Control gonad: raw134.47, 68–77/þ or raw155.27, 68–77/þ . (F) raw134.47, 6
Posterior right.ensheathment in heterozygous controls, raw mutants exhibited
ensheathment defects in 45% of gonads. Antibody staining using
the SGP cell surface marker Neurotactin (NRT), revealed clumps
of GCs surrounded by SGPs at the periphery of the gonad
(Fig. 1(A) and (B)), demonstrating that raw is required for GC
ensheathment by the SGPs and formation of a gonad with proper
architecture. Given the 45% frequency of ensheathment, it
appeared possible that the phenotype might be sex-speciﬁc.
However, examination of sexed male and female embryos
revealed that this was not the case (data not shown).
Since defects in gonad formation could arise from defects in
cell fate speciﬁcation, we wanted to conﬁrm that the SGPs were
speciﬁed properly. SGPs are speciﬁed from the mesoderm, and we
previously showed that other mesodermally derived tissues,
speciﬁcally the visceral mesoderm, formed normally in raw
mutants (Weyers et al., 2011). To examine SGP identity, we
analyzed expression of two markers expressed in SGPs, Eyes
absent/Clift (EYA/CLI) and TJ. EYA is required for SGP speciﬁcation
(Boyle et al., 1997; Boyle and DiNardo, 1995), while TJ is
expressed in SGPs from stage 13 onward (Li et al., 2003). In raw
mutants, EYA expression was observed in stage 12 SGPs, follow-
ing SGP speciﬁcation (Fig. 1(C) and (D) and Weyers et al., 2011),
and TJ was observed in SGPs from stage 13 onward (Fig. 1(E) and
(F); data not shown). Therefore, the defects in GC ensheathment
do not appear to be a result of improper SGP speciﬁcation or
identity, but rather defects in the communication or interaction
between the germline and soma.Ensheathment is required for proper germline development
We next wanted to test whether the defects in germ cell
ensheathment caused by raw mutants had effects on proper
soma-germline communication and germline development. In
males, GCs begin to proliferate at stage 15 of embryogenesis,
while they remain quiescent in females until late embryonic
stages (Sato et al., 2008; Wawersik et al., 2005). We examined
GC proliferation in raw mutants by scoring the number of gonads
that contained GCs positive for the mitotic marker phospho-
histone 3 (pH3). In control males, approximately 9% of gonadsd to examine germ cell ensheathment. (A, A0) 68–77/þ . (B, B0) raw134.47, 68–77/
(red, SGPs), and Neurotactin (NRT) (green, SGP cell surface). (A0 , B0) NRT alone.
peciﬁcation. SGPs are outlined with a white dashed line. (C) Control gonad: 68–77/
ge 15 embryos to assess SGP identity. Trafﬁc jam (green, SGPs) and VASA (blue,
8–77/raw155.27, 68–77 gonad. Scale bar: 10 mm for all immunoﬂuorescence images.
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mutant males, only 1% of gonads contained a mitotic GC
(Fig. 2(E)). In female controls and female raw mutants, pH3
positive GCs were not observed, consistent with previous results
(Fig. 2(E)). These results suggest that defects in GC ensheathment
affect the sexually dimorphic development of GCs.
Sex-speciﬁc signaling from the male SGPs to the GCs through
the JAK/STAT pathway regulates the proliferation of male GCs as
well as other sex-speciﬁc GC characteristics (Wawersik et al.,
2005). Male-speciﬁc activation of the JAK/STAT pathway can be
observed as an increase in STAT92E immunoreactivity in male
GCs (Wawersik et al., 2005), and we used this assay to test
whether the ensheathment defects in raw mutants interrupted
soma-GC signaling. While STAT92E immunoreactivity was
observed in the germline of raw heterozygous male control
embryos, raw mutant males failed to exhibit STAT92E expression
in their germline (Fig. 2(A) and (B)). The loss of STAT92E did not
correlate with the strength of the ensheathment defect in raw
mutant males. While STAT92E was reduced in all male gonadsFig. 2. Ensheathment regulates germ cell development. (A–D) STAT expression in stage
lacZ (red, SGPs), and STAT (green) (A0-D0) STAT alone. Posterior is to the right. Scale bar: 1
B0) Male raw134.47/raw155.27 gonads rarely express STAT in germ cells. (C, C0) Female raw h
for the presence of pH3 positive germ cells to assess germ cell proliferation.examined, not all gonads exhibited strong ensheathment defects
(data not shown). In females, STAT92E staining was not observed
in either controls or raw mutants (Fig. 2(C) and (D)), as expected.
We conclude that the failure of male GC proliferation observed in
raw mutants is due to defects in JAK/STAT signaling between the
soma and the germline, and therefore that the ensheathment of
the GCs by the SGPs is likely important for soma-germline
communication.
Raw negatively regulates JNK signaling
While raw is required for the morphogenesis of a number of
tissues during development, how it regulates these processes is not
well understood. Previous studies have shown that raw acts as a
negative regulator of JNK signaling during dorsal closure in
Drosophila (Bates et al., 2008; Byars et al., 1999), suggesting that
raw could function in a similar manner during gonad morphogen-
esis. In order to determine if JNK signaling is upregulated in raw
mutants, we examined expression of targets of the JNK pathway.17 embryonic gonads. Embryos immunostained for VASA (blue, germ cells), 68–77-
0 mm. (A, A0) Male raw heterozygous control gonads express STAT in germ cells. (B,
eterozygous controls. (D, D0) Female raw134.47/raw155.27. (E) Stage 15 gonads scored
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pathway target puckered (puc) to determine if its expression was
upregulated in or around the embryonic gonad. To do this, we used
an enhancer trap that had been shown to reﬂect increased levels of
JNK pathway activity in the dorsal ectoderm (Ring and Martinez
Arias, 1993). We found that this reporter exhibited increased
activity in raw mutants relative to controls (Fig. 3(A) and (B)).
Increased activity was observed in many different cell types in the
embryo, as previously reported (Byars et al., 1999). Higher levels of
activity were observed outside the gonad, compared to inside the
gonad (Fig. 3(A) and (B)); however, some activity was observed
within the gonad. puc-lacZ was increased in both GCs and SGPs
(Fig. 3(A) and (B)). To examine further whether expression of puc
truly reﬂects increased JNK pathway activity mediated by the
downstream AP-1 transcription factor, consisting of FOS and JUN
(Jun-related antigen or JRA, in Drosophila), we utilized a synthetic
GFP reporter that contains a multimerized AP-1 binding site
downstream of an hsp70 promoter (Chatterjee and Bohmann,
2012). Expression of this reporter was observed in the leading
edge of the dorsal ectoderm in wild-type embryos (Fig. 3(C)), a
place that is well known to be active for JNK pathway activity
(Glise et al., 1995; Hou et al., 1997; Sluss et al., 1996). In raw
mutants, broad upregulation of this reporter was observed
throughout the embryo (Fig. 3(D)). In the region of the embryonic
gonad, we observed no reporter expression in wild-type
embryos (Fig. 3(E)), while in raw mutants, the reporter was
strongly upregulated in cells surrounding the gonad, weakly
activated in the SGPs (Fig. 3(F)), and undetectable in the GCs. We
conclude that mutations in raw lead to a dramatically increasedFig. 3. JNK signaling is increased in raw mutants. (A) and (B) Stage 15 embryos immun
cells). (A0 , B0) puc-lacZ alone. (A, A0) raw heterozygous controls. (B, B0) raw134.47/raw155.2
expression in GCs. The gonad has been outlined with a dashed line. (C–F) Embryos imm
GFP AP-1 reporter (green). (E) and (F) Stage 15 embryos. TRE-GFP AP-1 reporter. (gree
heterozygous controls. Inset in E0 indicated by solid square. (D, F, F0) raw134.47/raw155.
square. The gonad has been outlined with a dashed line. Scale bar: 10 mm. Posterior isJUN transcriptional activity both in the region of the embryonic
gonad and in many other tissues.
We next wanted to examine how raw inﬂuences JNK pathway
activity. The most downstream component of the JNK pathway is
transcription factor AP-1, and so we examined expression of JRA
and FOS in raw mutants. While FOS expression was not changed
signiﬁcantly in raw mutants relative to controls (data not shown),
JRA expression appeared strikingly different in raw mutants, both
in the gonad and in the surrounding tissue (Fig. 4(A) and (B)). In
raw mutants, JRA immunoreactivity appeared more intense and
concentrated in a smaller subcellular region relative to controls
(Fig. 4(A) and (B)). When we restored raw expression to a subset
of cells in raw-mutant embryos, using a driver that is expressed in
a pair-rule pattern (prd-Gal4), we observed a decreased intensity
of JRA nuclear staining in regions where raw was expressed
(Fig. S1). In order to examine overall JRA protein levels, we
performed Western blot analysis on lysates from control and
raw mutant embryos. Surprisingly, we did not observe a signiﬁ-
cant increase in total JRA protein in raw mutants relative to
controls (Fig. 4(C); quantiﬁcation of JRA relative to alpha-tubulin
loading control reveals the ratio of raw/wt¼0.85, std. dev.¼0.12,
n¼3), despite the apparent increase in JRA levels upon immu-
nostaining. Therefore, we next asked if the more concentrated
immunoreactivity of JRA in raw mutants reﬂects increased loca-
lization to the nucleus relative to the cytoplasm. To do this, we
compared JRA immunostaining to that of another SGP transcrip-
tion factor, TJ, and quantiﬁed the ﬂuorescence intensity in
different regions. TJ was used, as it colocalized with DAPI, but
had a more uniform distribution in the nucleus than DAPI, makingostained for a puc-lacZ enhancer trap (green), TJ (red, SGPs), and VASA (blue, germ
7. Arrows indicate pucE69-lacZ expression in SGPs; arrowheads indicate pucE69-lacZ
unostained to label the TRE-GFP AP-1 reporter. (C) and (D) Stage 13 embryos. TRE-
n), VASA (blue, germ cells), and TJ (red, SGPs). (E0 , F0) GFP alone. (C, E, E0) raw134.47
27. Arrows indicate TRE-GFP expression in the SGPs. Inset in F0 indicated by solid
to the right.
Fig. 4. Raw regulates JRA subcellular localization. (A) and (B) Stage 15 embryos immunostained stained for JRA (green), TJ (red, SGPs), VASA (blue, germ cells). (A0 , B0) JRA
alone. (A, A0) raw heterozygous controls. (B, B0) raw134.47/raw155.27. The gonad has been outlined with a dashed line. Scale bar: 10 mm. Posterior is to the right. Arrows
indicate SGPs with altered JRA expression. (C) Western blot to analyze JRA levels in raw134.47/raw155.27 mutant embryos relative to controls. Lane 1 is control embryos (þ/þ
or raw155.27/þ or raw134.47/þ). Lane 2 is raw-(raw134.47/raw155.27 embryos). (D) Quantitation of TJ and JRA immunoﬂuorescence intensity within the nucleus and in ﬂanking
regions. See methods for details. (E) and (F) Representative plots of JRA and TJ immunoﬂuoresence intensity in individual SGPs in raw heterozygous controls (E) or
raw134.47/raw155.27 (F). Note that JRA is more uniform across the cell in controls (E) but co-localizes more closely with TJ (nucleus) in raw mutants (F).
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(Fig. S2). In wild-type embryos, JRA staining was relatively uni-
form across the cell, whereas TJ staining was increased in the
nuclear region of the cell (Fig. 4(D) and (E)). In contrast, in raw
mutants, JRA immunostaining across a cell more closely
resembled that of TJ (Fig. 4(D) and (F)). To compare nuclear levels
vs. cytoplasmic levels across many individual SGPs, we deﬁned
the TJ ‘‘bright’’ region as the nucleus, and compared JRA ﬂuores-
cence intensity relative to TJ intensity in the TJ ‘‘bright’’ vs.
ﬂanking region of the cell (Fig. 4(D) and (F)). We found that thelevels of nuclear JRA increased dramatically in raw mutants
relative to controls (Fig. 4(D)). Based on this analysis, we conclude
that loss of raw function results in increased nuclear localization
of JRA, and that raw may normally act as a negative regulator of
the JNK pathway by restricting access of JRA to the nucleus.
Increased JNK signaling causes ensheathment defects
The above results suggest that the ensheathment defects
observed in raw mutants occurred as a result of increased JNK
J.C. Jemc et al. / Developmental Biology 367 (2012) 114–125120signaling. If this is the case, we expected that mutating members
of the JNK signaling pathway would suppress the ensheathment
defects observed in raw mutants. To test this hypothesis, we
examined embryos that were homozygous mutant for raw and
also heterozygous for mutations in the Drosophila JNK, basket
(bsk), or jra. In both cases we observed a suppression of the raw
ensheathment defect (Fig. 5(A)). To further decrease the activity
of the JNK pathway, we expressed a dominant negative form of
UAS-bsk in raw mutants. In this case, we observed a stronger
suppression of the raw mutant phenotype (Fig. 5(A)). These
results suggest that the raw phenotype is caused by the increase
in JNK signaling. If this is the case, we expected that directly
increasing JNK signaling would be sufﬁcient to cause defects in GC
ensheathment independent of raw. To test this, we examined
the effect of removing the negative feedback regulator of JNK
signaling, puc. We found that puc heterozygotes exhibited
a 25% frequency of ensheathment defects compared to only 11%
in controls, while puc homozygous mutants exhibited a 50%0 
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a similar penetrance to raw mutants. These results demonstrate
that increasing JNK signaling is sufﬁcient to cause ensheathment
defects.
Raw regulates cadherin-based adhesion
JNK signaling has been demonstrated to affect a number of
cellular processes including cell adhesion, leading us to ask if the
function of cell adhesion proteins is affected in raw mutants. The
ensheathment defects observed in raw mutants are very similar
to those previously seen in mutants for Drosophila E-cadherin
(DE-cad) (Jenkins et al., 2003), which is encoded by the shotgun
(shg) locus (Tepass et al., 1996). Therefore, we examined the
possibility that decreased DE-cad function might be responsible
for the raw mutant phenotype. If this is the case, we expect that
mutating a single copy of shg in a raw mutant should enhance
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mutants (Fig. 6(A)). Embryos homozygous mutant for both raw
and shg exhibited an even greater frequency of ensheathment
defects (Fig. 6(A)). This is still consistent with the genes being in
the same pathway, rather than parallel pathways, as both genes
are known to be contributed maternally. To determine whether
defects in DE-cad function are the primary defect in raw mutant
gonads, we determined whether forced expression of DE-cad
paternally could rescue the raw mutant phenotype. Surprisingly,
expression of additional DE-cad using the alpha-tubulin promoter
(Pacquelet et al., 2003) was sufﬁcient to strongly rescue the
ensheathment defects in raw mutant gonads. Since the alpha-
tubulin promoter is expressed in the soma but not the germline
(Fig. S3 and Mathews et al., 2006), it is likely that raw causes
defects in GC ensheathment primarily by affecting DE-cad func-
tion in the soma.
Given that raw and DE-cad appear to function cooperatively to
mediate germline-soma interactions, we next wanted to examine
DE-cad protein in raw mutants. We examined DE-cad protein
levels using Western blot analysis on raw mutant embryos
compared to controls and found only a small reduction in
DE-cad levels in raw mutants (Fig. 6(B); raw/wt¼0.82, Std.
Dev.¼0.03, n¼2). Though DE-cad levels were not strongly
affected in raw mutants, it remained possible that its localization
or function could be affected, and so we examined DE-cad
localization by immunostaining. We found that DE-cad is still
localized to sites of SGP–GC interaction in raw mutants similar to
controls (Fig. 6(C) and (D)). To further address DE-cad function,
we examined the localization of another member of the cadherin
adhesion complex, b-catenin, which is encoded by armadillo (arm)
in Drosophila. In contrast to what we observed with DE-cad, we
ﬁnd that ARM localization to the membrane is strongly decreased
in raw mutants (Fig. 6(E) and (F)). The decrease in ARM immu-
nostaining correlated with germ cell ensheathment defects; those
embryos with ensheathment defects were also the embryos that
exhibited the clearest decreases in ARM staining (Fig. 6(G)). One
way in which ß-catenin interaction with cadherins is known to be
regulated is through phosphorylation (Aberle et al., 1997; Lee
et al., 2009; Lilien and Balsamo, 2005). Indeed, a slight increase in
the S44P/S48P phosphoform of ARM is observed in whole-embryo
extracts from raw mutants relative to controls, while total ARM
levels appear unchanged (Fig. 6(H)). Finally, since the raw mutant
ensheathment defect can be rescued by overexpression of DE-cad,
we examined whether ARM immunolocalization was also rescued
in these embryos. Indeed, in raw mutants overexpressing DE-cad
we observed an increase in ARM immunostaining that was now
comparable to controls overexpressing DE-cad (Fig. 6(I) and (J)).
Based on these results, we propose a model in which Raw acts as a
negative regulator of the JNK pathway, which, in turn acts to
negatively regulate DE-cad-based adhesion, at least in part by
inﬂuencing the localization of ARM/ß-catenin.
An alternative model, however, is that raw primarily acts by
affecting cadherin-based adhesion, and that changes in cell-cell
adhesion lead to the observed changes in JNK pathway activity
and JRA localization. To distinguish between these models, we
tested whether DE-cad acts upstream or downstream of the JNK
pathway in germ cell ensheathment. To do this, we examined JRA
localization in raw mutants that have been rescued by over-
expression of DE-cad. If the JNK pathway acts upstream of DE-cad,
we expect that expression of DE-cad would rescue the raw
mutant defects but would not affect JRA localization. However,
if it is the changes in DE-cad function that lead to the changes in
JRA localization, then we would expect DE-cad expression should
rescue both the ensheathment defects and the changes in JRA
localization. We found that, in raw mutants in which DE-cad is
overexpressed, we do not observe a change in JRA localization(Fig. S4), even though the ensheathment defects were rescued
(Fig. 6(A)). This supports the model that JNK signaling acts
upstream of DE-cad/ARM and that raw mutants affect DE-cad/
ARM function by causing an upregulation of the JNK pathway.Discussion
Here we have shown that raw is an important regulator of
embryonic gonad morphogenesis and the establishment of proper
gonad architecture. raw mutants exhibit a failure of SGPs to
ensheath GCs in the gonad, resulting in defects in GC develop-
ment. We have also found that raw affects gonad morphogenesis
primarily by acting as a negative regulator of the JNK signaling
pathway. Finally, we ﬁnd that raw mutants exhibit defects in
cadherin-based cell adhesion, and that this is the primary cause of
the failure of gonad morphogenesis. These results have clear
implications for our understanding of how important cell signal-
ing pathways are regulated to control normal organogenesis and
may be misregulated to cause disease.
Raw is a negative regulator of the JNK pathway
Previously, raw has been proposed to be a negative regulator of
the JNK pathway during closure of the dorsal epidermis, based on
changes in JNK-dependent expression of target genes such as dpp
and puc (Bates et al., 2008; Byars et al., 1999). Indeed, we have also
seen an increase in puc expression in the region of the embryonic
gonad, and more broadly throughout the embryo (Fig. 3). Further,
we observed upregulation of a dedicated AP-1 reporter construct
(Fig. 3), indicating that the changes in target gene expression are
directly due to changes in AP-1 transcriptional activity regulated by
the JNK pathway. When we upregulated the JNK pathway via
independent means, we observed similar defects in gonad morpho-
genesis, indicating that the changes in the JNK pathway were the
primary mechanism by which raw mutants cause gonad defects.
Therefore, our results support and extend the previous observations
that raw acts as a negative regulator of JNK pathway, both in the
gonad and in other tissues in which raw mutants exhibit defects in
morphogenesis.
How might raw be regulating the JNK pathway? Our evidence
indicates that raw regulates the JNK pathway at the level of
transcription factor JRA. We found that the nuclear localization of
JRA, but not FOS, was altered in raw mutants. JRA was more
strongly concentrated in the nucleus in a variety of cell types in
raw mutants, whereas we did not observe changes in the global
levels of JRA protein. These observations are consistent with
previous genetic epistasis experiments that indicated that raw
acts at the level of JRA, rather than further upstream in the
pathway (Bates et al., 2008). It has been proposed that raw acts as
a general negative regulator of the JNK pathway to suppress basal
activity and perhaps establish a threshold for pathway activation
(Bates et al., 2008; Byars et al., 1999). Our data are consistent with
this hypothesis, as we saw a general nuclear accumulation of JRA
in a variety of cell types in the embryo (Fig. 4), along with
generalized activation of the transcriptional reporter for AP-1
activity (Fig. 3). Presumably, not all of these different cells are
normally exposed to activators of the JNK pathway at this time,
indicating that the pathway may be activated in cells in which the
pathway would normally be turned off. Thus, rather than being
just a modulator of the level of signal a cell might receive under
conditions of JNK pathway activation, raw is likely also respon-
sible for ensuring that the pathway remains inactive in cells that
are not experiencing pathway activation.
It is difﬁcult to predict exactly how Raw may be regulating JNK
signaling, as the Raw protein has no readily identiﬁable protein
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species. It may be the case that similar JNK pathway regulators
are present in other species and have structural and/or functional
conservation with Raw, but are difﬁcult to identify based on
primary sequence homology. Studies examining the subcellular
localization of Raw in cultured mammalian (Bates et al., 2008) or
Drosophila (Jemc and Van Doren, unpublished data) cells indicate
that it is primarily found in the cytoplasm. One attractive
hypothesis is that Raw directly binds to JRA to block its nuclear
translocation and sequester JRA in the cytoplasm. Unfortunately,
our efforts to identify a direct, physical interaction between Raw
and JRA have so far been unsuccessful.
The JNK pathway is subject to negative regulation at several
levels. Most familiar are the MAP kinase phosphatases (MKPs, a
subfamily of Dual-speciﬁcity phosphatases), like Drosophila Puck-
ered (Martin-Blanco et al., 1998), that provide negative feedback
by dephosphorylating activated MAP kinases such as JNK
(Bermudez et al., 2010). Additional modes of regulation include
nuclear repressors of AP-1 target genes (e.g., Anterior open,
(Riesgo-Escovar and Hafen, 1997)) and a secreted protease that
acts in negative feedback on the JNK pathway (Scarface, (Rousset
et al., 2010; Sorrosal et al., 2010)). Raw appears to represent a
distinct mode of regulation, acting on the ability of JRA/JUN to
translocate to the nucleus. Regulation of the subcellular localiza-
tion of transcription factors and cofactors is a strategy that is
commonly deployed to regulate signaling pathway activity, and
many transcription factors are sequestered in the cytoplasm as a
mechanism for negatively regulating their activity. We propose
that JRA is subject to such regulation as a means to repress its
activity in cells that are not experiencing sufﬁcient levels of JNK
pathway activity.
Further studies of Raw are necessary to determine how Raw
functions at a molecular level to regulate JRA subcellular localization.Raw regulates cadherin-based adhesion in the gonad
We have found that raw mutants also exhibit defects in
cadherin-based cell adhesion, which is known to be important
for proper gonad morphogenesis and GC ensheathment by SGPs
(Jenkins et al., 2003; Van Doren et al., 2003). Loss of DE-cad
function exacerbates the gonad defects observed in raw mutants
while increasing DE-cad function strikingly rescues these defects
(Fig. 6). It is likely that the increase in JNK pathway activity in raw
mutants leads to defects in DE-cad-based adhesion and that this
is the primary cause of the gonad morphogenesis defects. This is
in contrast to the role of raw and the JNK pathway in the closure
of the dorsal epidermis, which is largely thought to be due to
regulation of dpp expression (Byars et al., 1999). Consistent with
this, we observed less up-regulation of dpp in the region of the
gonad, relative to the overall activation of the AP-1 transcriptional
reporter (Fig. 3 and data not shown).
Previous studies in mammalian cells have implicated JNK
signaling in negative regulation of cadherin-based cell adhesion
(Lee et al., 2009), while in other contexts the JNK pathway has
also been observed to upregulate DE-cad (Dobens et al., 2001).
Our results favor a repressive role for the JNK pathway on DE-cad
in the gonad. It is also known that cadherins can act upstream of
the JNK pathway, and that loss of cadherin can lead to an increase
in c-Jun protein levels (Knirsh et al., 2009). However, our results
are consistent with DE-cad acting downstream of the JNK path-
way, since DE-cadherin expression could rescue gonad morpho-
genesis independently of rescuing JRA localization (Fig. 6 and S4).
We conclude that during gonad morphogenesis, raw acts as a
negative regulator of the JNK pathway, and increased JNK path-
way activity observed in raw mutants leads to a downregulationof DE-cadherin based cell adhesion and a failure of proper
ensheathment of the GCs by the somatic gonad.
While we did not observe a change in DE-cad localization in
the gonad, the localization of ARM/ß-catenin was dramatically
altered. Since ARM is essential for proper DE-cad function in cell
adhesion (Gorﬁnkiel and Arias, 2007; Pacquelet et al., 2003), this
indicates that DE-cadherin-based adhesion is strongly affected in
raw mutants. It has been shown that JNK can directly phosphor-
ylate ß-catenin and negatively regulate its activity (Lee et al.,
2009). Consistent with this, we observed a modest increase in the
relevant phospho-form of ARM/ß-catenin in raw mutants (Fig. 6).
Thus, this may represent one aspect of how the JNK pathway
regulates DE-cad based adhesion in the gonad. However, the
change in ARM/ß-catenin phosphorylation observed is unlikely
to account for the more dramatic change in ARM/ß-catenin
immunostaining observed in the gonad. Considering that we also
observe a strong increase in transcriptional activation by AP-1 in
raw mutants, and that mutations in the JRA transcription factor
can partially suppress the gonad morphogenesis defects observed
in raw mutants, we conclude that at least some of the JNK
pathway effect on DE-cad function and ß-catenin localization is
likely to depend on changes in gene expression mediated by AP-1.
Since we did not observe overall changes in protein levels for DE-
cad or ARM/ß-catenin in raw mutants, the changes in gene
expression may reﬂect changes in other regulators of DE-cad
based cell adhesion. Interestingly, our previous work identiﬁed a
zinc transporter, Fear of intimacy, that also affects gonad mor-
phogenesis and GC ensheathment by regulating DE-cad (Mathews
et al., 2006,2005; Van Doren et al., 2003). Regardless of whether
there is an interesting connection between zinc transport and the
JNK pathway, or these represent independent pathways, they
highlight the importance of careful regulation of cadherin-based
cell adhesion in controlling morphogenesis.
Our previous work has indicated that GC ensheathment
requires preferential adhesion between SGPs and GCs, such that
SGP–GC adhesion is favored over GC–GC or SGP–SGP adhesion
(Jenkins et al., 2003). Indeed, just increasing the adhesion
between GCs via DE-cadherin expression in these cells is sufﬁ-
cient to prevent ensheathment of the GCs by SGPs (Jenkins et al.,
2003). In raw mutants, we primarily observe changes in the JNK
pathway in SGPs and surrounding somatic cells. In addition,
expression of DE-cad in the soma, but not the germline, is
sufﬁcient to rescue the ensheathment defects in raw mutants.
Together, these data indicate that raw mutants likely affect gonad
ensheathment by decreasing DE-cad function in the SGPs, which
decreases SGP–GC adhesion relative to GC–GC adhesion. While it
is possible that effects of raw on somatic cells outside of the
gonad affect ensheathment within the gonad, it is less easy to
imagine how decreasing DE-cad activity in these cells would
inﬂuence ensheathment.Regulation of JNK in development and disease
The JNK pathway has been implicated in many diseases,
including birth defects, neurodegeneration, inﬂammatory dis-
eases, and cancer, to name a few (Johnson and Nakamura,
2007). Signaling pathways must be tightly regulated both posi-
tively, to ensure rapid and robust signaling responses, and
negatively, to terminate signaling events and prevent inappropri-
ate signaling. As a negative regulator of JNK pathway signaling,
raw represents the type of gene that might be mutated or
misregulated in diseases caused by altered JNK pathway activity.
This idea is supported by the strong developmental phenotypes
associated with mutations in negative regulators of the JNK
pathway in Drosophila (Bates et al., 2008; Byars et al., 1999;
J.C. Jemc et al. / Developmental Biology 367 (2012) 114–125124Rousset et al., 2010; Sorrosal et al., 2010) and mice (Bermudez
et al., 2010).
One disease where the JNK pathway has been particularly well
studied is cancer. The JNK pathway’s role in cancer is complex,
however, and the pathway can act in tumor suppression or
oncogenesis, depending on the context (Shaulian, 2010). In mouse
and Drosophila models of cancer due to activated Ras, upregula-
tion of the JNK pathway is required for tumor formation and
disease progression (Cellurale et al., 2011; Igaki et al., 2006;
Uhlirova and Bohmann, 2006). Interestingly, downregulation of
E-cadherin is also associated with cancer progression (Berx and
van Roy, 2009), including in the models of activated Ras where
the JNK pathway is involved (Cellurale et al., 2011; Igaki et al.,
2006). Thus, a similar link between the JNK pathway and cadherin
regulation that we observed in morphogenesis of the gonad
during development may play a role in oncogenesis. Since
upregulation of the JNK pathway promotes cancer in these
examples, negative regulators of the pathway such as the MAPK
phosphatases or Raw would act as tumor suppressors whose
mutation could contribute to disease progression. A better under-
standing of how the JNK pathway is regulated, and how Raw
contributes to this regulation, is essential for understanding the
normal roles of the JNK pathway in development and home-
ostasis, and how it is misregulated to cause disease.Acknowledgments
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